Work

P-244 Feasibility, safety, and biodistribution of 18F-BMS-986229 PET in patients with esophagogastric (EG) cancer

Year: 2022

Type: conference-abstract

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2022.04.334

Authors: S. Cytryn, M. Lumish, V. Paroder, S. Philemond, J. Lewis, S. Lyashchenko, Y. Janjigian, N. Pandit-Taskar

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Defense, Eli Lilly and Company, Pfizer, AstraZeneca, Bayer Fund, Cycle for Survival, Daiichi-Sankyo, Basilea Pharmaceutica, National Cancer Institute

OpenAlex ID: W4283785338

Cites:

Cited by: 4

Related to: 10